Adoram
  • Home
  • Contact us
  • Home
  • Home_v2_html_Claude
  • News
Select Page
Follow us online

Follow us online

by heshamhamed | Aug 11, 2022 | News

Adoram Therapeutics has recently been accepted into the Swiss Biotech Association. Our Swiss Biotech company page and Venture Platform listing (for business partnering and investor interactions) can found here Adoram Therapeutics SA...

Recent Posts

  • Press release: Adoram Therapeutics Secures CHF 1 Million Grant from Innosuisse for Anti-inflammatory Drug Research
  • Adoram primary asset published in the Journal of Medicinal Chemistry, January 24th 2025
  • Press release: Adoram Therapeutics Secures Pre-Seed Investment to Advance Innovative Cancer Immunotherapy and Inflammation Programs
  • Adoram Therapeutics receives funding from FONGIT Innovation Fund
  • South Summit International Startup Competition. June 5-7th, 2024

Recent Comments

No comments to show.

Archives

  • May 2025
  • February 2025
  • January 2025
  • February 2024
  • November 2022
  • October 2022
  • August 2022
  • June 2022

Categories

  • News